The Promise and Challenge of Big Data for Pharma
Harvard Business
NOVEMBER 29, 2016
One of the biggest is how to make the transition from legacy technology and analytical competence to more-powerful and sophisticated analytical tools and analysis methodologies. It will increasingly help government health agencies, payers, and providers to make decisions about such issues as drug discovery, patient access, and marketing.
28 
Let's personalize your content